CA
APTO

Cetera Advisors’s Aptose Biosciences, Inc. APTO Stock Holding History

Cetera Advisors’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$35.4K Sell
711
-101
-12% -$5.78K ﹤0.01% 2368
2023
Q4 		$61.1K Buy
812
+312
+62% +$24.2K ﹤0.01% 1731
2023
Q3 		$42K Buy
+500
New +$58.9K ﹤0.01% 1656
2023
Q2 		– Sell
-193
Closed -$55.8K – 1797
2023
Q1 		$55.8K Hold
193
– – ﹤0.01% 1592
2022
Q4 		$50.4K Buy
193
+55
+40% +$14.8K ﹤0.01% 1547
2022
Q3 		$37K Hold
138
– – ﹤0.01% 1240
2022
Q2 		$46K Buy
138
+3
+2% +$1.44K ﹤0.01% 1330
2022
Q1 		$83K Buy
135
+63
+88% +$34.8K ﹤0.01% 1364
2021
Q4 		$44K Buy
72
+45
+167% +$42.3K ﹤0.01% 1402
2021
Q3 		$27K Buy
27
+4
+17% +$5K ﹤0.01% 1387
2021
Q2 		$34K Buy
+23
New +$50.1K ﹤0.01% 1306

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.52B AUM 18.08% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Cetera Advisors's APTO Position: Q1 2024 in Review

Cetera Advisors reduced its Aptose Biosciences, Inc. (APTO) stake by 12% in Q1 2024, selling an estimated $5.78K and leaving 711 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2368.

Cetera Advisors first reported a position in APTO in Q2 2021 and has held it in 11 quarters since. The position peaked at $83K in Q1 2022. 24 funds tracked by Wall St. Rank hold APTO as of Q1 2024.

  • Cetera Advisors held 711 shares of Aptose Biosciences, Inc. worth $35.4K as of Q1 2024.
  • Cetera Advisors sold 101 Aptose Biosciences, Inc. shares in Q1 2024, an estimated $5.78K.
  • Aptose Biosciences, Inc. made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2368 holding.
  • Cetera Advisors first reported a position in Aptose Biosciences, Inc. in Q2 2021 and has held it in 11 quarters since.
  • Cetera Advisors's Aptose Biosciences, Inc. position peaked at $83K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.